Abstract
In this work, we describe a novel DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) based ligand with a chromophoric tropone coordinating sidearm (1). Ln3+ complexes of 1 have one inner sphere water molecule. The r1 relaxivity of Gd1 is similar to that of the commercial Gd-based MRI agents. The neutral O-donor atom of the tropone moiety slows down the water exchange rate by a factor of 3 compared to GdDOTA. In addition, Nd1 and Yb1 complexes exhibit significant NIR emission in aqueous solutions indicating that the tropone unit is an efficient sensitizer for these Ln3+-ions. Therefore, this new ligand is a promising platform for the design of Ln3+ based dual MR/optical imaging probes.
Keywords: Lanthanide, MRI, Near-infrared, tropone, imaging
COMMUNICATION

A DOTA derivative with a tropone coordinating sidearm forms monohydrated lanthanide complexes. The Gd3+-chelate has the expected relaxivity while the Nd3+ and Yb3+ complexes exhibit bright NIR luminescence despite the quenching effect of the inner sphere water molecule.
Lanthanide ions (Ln3+) have been involved in a large number of applications as components of magnetic resonance and optical imaging agents as a result of their unique magnetic and optical properties. Gd3+- and Eu3+-complexes are well established as MR imaging contrast agents[1] while several other Ln3+ have been explored for their luminescent properties in the visible or near-infrared (NIR) range.[2] Ln3+-based luminescent probes have several favorable properties for bio applications that include narrow emission bands, large difference between excitation and emission wavelengths and strong resistance towards photobleaching.[2a–c] Current research is focusing on NIR probes because of the potential deep tissue penetration of NIR photons and low autofluorescence of biological tissues in this range.[2c–f] Lanthanide ions share similar coordination chemistry, thus one can explore the entire lanthanide series with the same ligand. This versatility makes it possible to construct agents for combined or dual MR/optical imaging that contain Gd3+ for MRI and another lanthanide, such as Nd3+ or Yb3+ for NIR optical detection. The structural similarity of lanthanide complexes allows the co-localization of the MR and optical images due to similar biodistributions.[3] Dual MR /optical imaging is advantageous because it combines the high spatial resolution of MRI at the anatomical level with the high sensitivity of optical detection at the cellular level.[3,4] The ligand in such dual agents should fulfill several requirements: form thermodynamically stable and kinetically inert complexes with Ln3+ to prevent toxicity associated with free lanthanide ions, provide a mechanism for the efficient paramagnetic relaxation enhancement of the bulk water protons and sensitize characteristic emission of a luminescent lanthanide ion (antenna effect). This last point is particularly important since most of f-f- transitions of Ln3+ are Laporte-forbidden and exhibit very low molar absorption coefficients making their direct excitation difficult.[2,3] However, this problem can be overcome if the organic ligand includes an appropriate chromophoric moiety that can absorb excitation energy and transfer it to the corresponding Ln3+.[2,3] Efficient relaxation of bulk water protons by Gd3+ requires at least one rapidly exchanging inner sphere water molecule,[1] but this requirement appears to be incompatible with the design of optical agents, especially those emitting in the NIR range, because the overtones of O-H vibrations can quench the Ln3+ excited states through non-radiative deactivation.[5] It has been shown, however, that in some Ln3+-based complexes, the NIR emission can be efficiently sensitized despite the presence of several coordinated water molecules.[6] Nevertheless, such examples remain very scarce.[3,6] Here we report a new ligand (1, Figure 1), whose lanthanide complexes (Ln1, Ln = Nd, Gd, Yb) have one inner-sphere water molecule and yet, Nd1 and Yb1 display bright luminescence in the NIR domain. The ligand contains a tropone (cyclohepta-2,4,6-trien-1-one) chromophore appended on a DO3A (1,4,7,10-tetraazacyclodoecane-1,4,7-triacetic acid) unit (Figure 1). Lanthanide chelates of DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) and related ligands have been shown to have high in vivo stability and are frequently used for various biomedical applications.[7] Tropolone (2-hydroxytropone) is a seven membered, non-benzenoid aromatic compound.[8] Its pKa is around 7 and the tropolonate anion can act as a bidentate ligand for alkaline earth, transition metal and lanthanide ions.[8,9] The electronic structure of the coordinated tropolone moiety enables it to be an efficient sensitizer for several NIR-emitting Ln3+ ions in solution[10] However, the thermodynamic stability and kinetic inertness of lanthanide tropolonato complexes is not sufficient for in vivo applications.[9]
Figure 1.
Structure of DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid), tropolone and DO3A-tropone (1) discussed in this work.
Tropones with a leaving group (-Cl, -Br or -OTs) at position 2 easily undergo aromatic nucleophilic substitution.[8] We have chosen DO3A-tris(tert-butyl ester) as starting material, which reacted cleanly with the commercially available tropolone-p-toluenesulfonate to give the expected tert-butyl protected product (Scheme S1, Supporting Information). Acidic hydrolysis of the tert-butyl groups gave the desired ligand as free acid in good yield. Ligand 1 is expected to form neutral chelates with trivalent metal ions. The lanthanide complexes Ln1 were prepared by adding LnCl3 (Ln = Gd, Eu, Nd and Yb) to the ligand at pH 6 in the presence of OH-form anion exchange resin as a base. 1H NMR spectra (Figure S1) indicated that the structure of the Nd3+ complex adopts a twisted square antiprism (TSAP) geometry. Eu1 is present in solution predominantly as the square antiprism (SAP) isomer with approximately 20 % of the TSAP form while and Yb3+ chelate exclusively formed the SAP isomer. This behavior is analogous to that of the corresponding DOTA complexes and can be explained to the lanthanide contraction.[11]
The relaxivity (Figure S2) of the Gd1 complex was found to be 3.46 mM−1s−1 at 1.4 T and 37 °C in water. This value falls in the range that is expected for a small molecular weight complex with one water molecule bound to the Gd3+.[1a] The number of inner-sphere water molecules in Gd1 was measured by 17O NMR bulk magnetic susceptibility water shift measurements (q = 1) (Supporting Information). Since the tropone sidearm has a neutral oxygen donor atom, we anticipated that this would significantly decrease the exchange rate compared to a negatively charged carboxylate coordinating group.[1b] Variable temperature 17O NMR measurements revealed that the exchange rate of the inner sphere water molecule in Gd1 was indeed about 3 times slower than that in the parent complex Gd-DOTA (Figures 2, S3 and Table S1).
Figure 2.
Temperature dependence of the reduced 17O NMR transverse relaxation rates of Gd1 (●) and GdDOTA (
) as reference.
While this value is not optimal, it did not affect the r1 significantly because it is still in the range where the relaxivity is limited by the short rotational correlation time of the complex[1a]. However, slowing down the tumbling rate should result in an increase of relaxivity.[1a] We anticipated that the complex might bind to albumin (HSA) because of the presence of the lipophilic tropone moiety. Therefore, the binding of Gd1 to albumin was studied by adding increasing amounts of albumin to the complex and measuring the relaxation rate of the solution. The r1 did not improve dramatically in the presence of albumin. Fitting of the data revealed a weak binding to HSA with an affinity constant of KA = 0.6 mM−1, which does not significantly increase the r1 value of the complex in the concentration range relevant for MR imaging (Figure S4 and Table S2).
In vivo MR imaging experiments with Gd1 revealed that as expected, the agent was excreted by the kidneys and the liver. The presence of the intact complex in urine was confirmed by MS. Gd1 did not show any toxicity at the injected doses (Figure S5).
The photophysical properties of Gd1, Nd1 and Yb1 were studied by recording the absorption, excitation and emission spectra (Figure 3). The absorption spectra of aqueous solutions of Ln1 chelates were found to be fairly similar to each other and display broad bands in the range 250–400 nm due to ligand-centered π*←π electronic transitions with the lower energy absorption maxima located around 330 nm. Upon excitation of the ligand-centered bands at 340 nm, the Yb3+ and Nd3+ complexes exhibited characteristic emission in the NIR arising from the 2F5/2→2F7/2 and 4F3/2 →4IJ (J = 9/2, 11/2, 13/2) transitions, respectively. The excitation spectra of Yb1 and Nd1 recorded upon monitoring the main transitions at 980 and 1064 nm, respectively, displayed broad bands in the range 250–400 nm. This confirms that the sensitization of these ions occurs through the ligand-centered levels (antenna effect).[2] The energy position of the ligand triplet state was determined from the phosphorescence spectrum of Gd1 as a 0-0 transition at 17,460 cm−1 (572.5 nm) (see discussion and Figure S5, Supporting Information). This value is slightly higher but still comparable to the reported value for tropolone, 16,800 cm−1.[12] Thus, the energy of the ligand triplet state is higher than the corresponding emitting levels of Nd3+ and Yb3+ (ENd(4F3/2) = 11,460 cm−1, and EYb(2F5/2) = 10,300 cm−1,)[13] facilitating their population through ligand-to-metal energy transfer. The experimental luminescence decays (Figure S6) were best fitted by monoexponential functions reflecting the presence of only one Ln3+-containing emitting species in solutions. Comparison of the luminescence lifetimes in H2O and D2O buffered solutions and the use of phenomenological equations[5, 14] allowed the estimation of the number of inner sphere water molecules (Figure S7). The value of q=0.8±0.2 was found for both Yb1 and Nd1, which is in a good agreement with the one obtained for Gd1 from susceptibility measurements. The absolute quantum yields measured in HEPES at pH 7.4 and D2O under ligand excitation at 340 nm are summarized in Table 1. While these quantum yields are several orders of magnitude lower in comparison to those reported for organic fluorophores, they are fairly high for hydrated lanthanide chelates.[15] The higher quantum yield values and longer luminescence lifetimes in D2O indicate the higher probability of non-radiative deactivation of Ln3+ ions through overtones of O-H (3,600 cm−1) rather than O-D (2,200 cm−1) vibrations.[16]
Figure 3.
UV-vis absorption (left), excitation (middle) and) NIR emission (right) spectra of Nd1 and Yb1 in HEPES buffer (200 µM, pH7.4, 25 °C).
Table 1.
Absolute quantum yields and observed luminescence lifetimes (200 µM in HEPES buffer at pH7.4, or D2O, 25 °C).
| Ln1 | Solvent | Quantum yield [%] | Lifetime [µs] |
|---|---|---|---|
| Nd1 | HEPES | 5.5(2)·10−3 | 0.084(2) |
| Nd1 | D2O | 2.68(1)·10−2 | 0.342(2) |
| Yb1 | HEPES | 6.7(2)·10−3 | 0.864(2) |
| Yb1 | D2O | 8.29(2)·10−2 | 7.75 |
It is worth noting that the tropone coordinating group could therefore be used to fine tune the water exchange rate of a lanthanide complex for applications where slow water exchange is preferred.[1b] Photophysical measurements revealed that the tropone unit of the ligand 1 is an efficient sensitizer for Nd3+ and Yb3+ allowing the detection of characteristic bright NIR emission in aqueous solutions. The favourable photophysical properties of the tropone chromophore combined with the DOTA framework offers a novel platform for the design of lanthanide-based dual MR/optical imaging agents for in vivo applications.
In conclusion, we have synthesized a novel DOTA-based ligand with a tropone sidearm. The Ln3+ complexes have one inner sphere water molecule. The Gd-complex has nearly the same r1 relaxivity as GdDOTA, which is generally considered as the “gold standard” for MRI contrast agents. The neutral O-donor atom of the tropone moiety slows down the water exchange rate by a factor of 3 relative to GdDOTA.
Experimental Section
Experimental Details are given in the Supporting Information
Supplementary Material
Acknowledgments
This work was supported in part by NIH (grant P41-EB015908) and La Ligue Contre le Cancer, La Region Centre, Agence Nationale de la Recherche (Lumzif ANR-12-BS07-0012, NIRA ANR-13-BS08-0011). S.P. acknowledges support from the Institut National de la Santé et de la Recherche Médicale (INSERM).
References
- 1.a) Caravan PE, Ellison JJ, Jeffrey J, McMurry TJ, Lauffer RB. Chem. Rev. 1999;99:2293–2352. doi: 10.1021/cr980440x. [DOI] [PubMed] [Google Scholar]; b) Viswanathan S, Kovacs Z, Green KN, Ratnakar SJ, Sherry AD. Chem. Rev. 2010;110:2960–3018. doi: 10.1021/cr900284a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Bünzli J-CG, Piguet C. Chem. Soc. Rev. 2005;34:1048–1077. doi: 10.1039/b406082m. [DOI] [PubMed] [Google Scholar]; b) Eliseeva SV, Bünzli J-CG. Chem. Soc. Rev. 2010;39:189–227. doi: 10.1039/b905604c. [DOI] [PubMed] [Google Scholar]; c) Bünzli J-CG, Eliseeva SV. Chem. Sci. 2013;4:1939–1949. [Google Scholar]; d) Foucault-Collet A, Gogick KA, White KA, Villette S, Pallier A, Collet G, Kieda C, Lib T, Geib SJ, Rosi NL, Petoud S. Proc. Natl. Acad. Sci. USA. 2013;110:17199–17204. doi: 10.1073/pnas.1305910110. [DOI] [PMC free article] [PubMed] [Google Scholar]; e) Foucault-Collet A, Shade CM, Nazarenko I, Petoud S, Eliseeva SV. Angew. Chem. 2014;53:2927–2930. doi: 10.1002/anie.201311028. [DOI] [PubMed] [Google Scholar]; f) Martinić I, Eliseeva SV, Petoud S. J. Lumin. 2017;189:19–43. [Google Scholar]
- 3.Bonnet CS, Toth E. C. R. Chim. 2010;13:700–714. [Google Scholar]
- 4.a) Verwilst P, Park S, Yoon B, Kim JS. Chem. Soc. Rev. 2015;44:1791–1806. doi: 10.1039/c4cs00336e. [DOI] [PubMed] [Google Scholar]; b) Kobayashi H, Longmire MR, Ogawa M, Choyke PL. Chem. Soc. Rev. 2011;40:4626–4648. doi: 10.1039/c1cs15077d. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Beeby A, Clarkson IM, Dickins RS, Faulkner S, Parker D, Royle L, de Sousa AS, Williams JAG, Woods M. J. Chem. Soc., Perkin Trans. 1999;2:493–504. [Google Scholar]
- 6.a) Caillé F, Bonnet CS, Buron F, Villette S, Helm L, Petoud S, Suzenet F, Toth E. Inorg. Chem. 2012;51:2522–2532. doi: 10.1021/ic202446e. [DOI] [PubMed] [Google Scholar]; b) Martins AF, Eliseeva SV, Carvalho HF, Teixeira JMC, Paula CTB, Hermann P, Platas-Iglesias C, Petoud S, Toth E, Geraldes CFGC. Chem. Eur. J. 2014;20:14834–14845. doi: 10.1002/chem.201403856. [DOI] [PubMed] [Google Scholar]
- 7.Brucher E, Tircso G, Baranyai Z, Kovacs Z, Sherry AD. In: The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging. 2. Merbach AE, Helm L, Toth E, editors. Wiley; Chichester, UK: 2013. pp. 157–208. [Google Scholar]
- 8.Pauson PL. Chem. Rev. 1955;55:9–136. [Google Scholar]
- 9.a) Zhang J, Badger PD, Geib SJ, Petoud S. Inorg. Chem. 2007;46:6473–6482. doi: 10.1021/ic7005343. [DOI] [PubMed] [Google Scholar]; b) Dutt Y, Singh RP, Katyal M. Talanta. 1969;16:1369–82. doi: 10.1016/0039-9140(69)80179-7. [DOI] [PubMed] [Google Scholar]
- 10.Zhang J, Badger PD, Geib SJ, Petoud S. Angew. Chem. Int. Ed. 2005;44:2508–12. doi: 10.1002/anie.200463081. [DOI] [PubMed] [Google Scholar]
- 11.Aime S, Botta M, Fasano M, Marques MPM, Geraldes CFGC, Pubanz D, Merbach AE. Inorg. Chem. 1997;36:2059–2068. doi: 10.1021/ic961364o. [DOI] [PubMed] [Google Scholar]
- 12.Murov SL, Carmichael I, Hug GL. Handbook of Photochemistry. 2. M. Dekker Inc.; New York: 1993. [Google Scholar]
- 13.Carnall WT, Fields PR, Rajnak K. J. Chem. Phys. 1968;49:4424–4442. [Google Scholar]
- 14.Faulkner S, Beeby A, Carrié M-C, Dadabhoy A, Kenwright AM, Sammes PG. Inorg. Chem. Commun. 2001;4:187–190. [Google Scholar]
- 15.Bünzli J-CG. Coord. Chem. Rev. 2015;293–294:19–47. [Google Scholar]
- 16.Bünzli J-CG, Eliseeva SV. In: Comprehensive Inorganic Chemistry II. Yam VW-W, editor. Vol. 8. Elsevier B.V.; Amsterdam: 2013. pp. 339–398. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.



